Updated:
Vynleads
Vynleads, led by CEO Sergio tabb, is a publicly listed digital health marketing firm that went public pre-revenue through a reverse merger.
Vynleads
Vynleads was incorporated in Nevada in 2014 under the leadership of CEO Sergio tabb. The company positions itself as a provider of digital marketing and patient engagement tools for the healthcare sector, explicitly targeting small to mid-sized medical practices. It became a publicly reporting entity through a reverse merger, completing the transaction that brought it onto the OTC Markets without a traditional IPO process or an accompanying capital raise. The firm's primary asset is a white-label platform intended to help healthcare providers deploy online lead-generation funnels, patient education sequences, and appointment reminders. The strategy relies on a direct-to-practice sales model rather than enterprise agreements with hospital systems. Deployment is concentrated in the United States, with no disclosed international operations. Financial disclosures filed with the SEC have consistently shown minimal revenue and negative cash flows from operations, making the firm's ability to deploy capital as a going concern its single most scrutinized metric. As a public filer, Vynleads reports a skeleton team structure: Sergio tabb remains the sole named officer across SEC filings, and the company's quarterly reports have referenced using third-party contractors for development and IT support. There are no disclosed external investment rounds from venture capital or strategic partners. Operating from New York, the firm's total assets have historically been stated below $100,000, making it an extreme outlier among publicly listed health-tech entities. Structurally, Vynleads differs from most health-tech startups by trading on a public market prior to achieving any meaningful revenue — meaning its cost of regulatory compliance as a reporting issuer has, in several periods, exceeded its top-line sales. This inverted operating structure creates an unusual dynamic where the public vehicle's primary value proposition may be its status as a publicly listed shell rather than its underlying platform traction.
General information
Firm type
other
Year founded
2014
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Sergio tabb
Chief Executive Officer & Director
Sector focus
Frequently asked questions
What is the key risk factor for a publicly traded firm with Vynleads' revenue profile?
Vynleads has consistently reported minimal revenue in its public filings with the SEC. As a going concern, the firm has relied on debt financing and capital contributions from its CEO, Sergio tabb, to fund operations. This funding structure concentrates the company's survival risk on a single individual's capacity and willingness to provide ongoing financial support.
Does Vynleads operate as a single-family office or an institutional asset manager?
No. Vynleads is an operating company providing digital marketing tools for healthcare practices. It has not raised external capital through the institutional LP channels typical of asset managers, nor does it manage wealth on behalf of a single-family unit. Its status as a publicly listed shell gives it some structural flexibility, but it functions as a health-tech operating company with negligible deployment capital.
What is the company's structure and how does it raise capital?
Vynleads became a publicly traded entity through a reverse merger, a path that sidestepped the traditional underwritten IPO process. As a public reporting company, it can theoretically raise capital through equity sales into the public market. However, filings indicate the firm has primarily stayed solvent through loans and cash advances from its CEO rather than through institutional placements or public market raises.
Who directly controls the strategic direction of Vynleads?
Sergio tabb serves as the company's CEO and sole director listed in its regulatory submissions. The firm's annual and quarterly reports filed with the SEC do not name a separate investment committee, CFO, or institutional board. This concentration of authority places strategic, operational, and financing decisions entirely with a single executive.
Where is the company's intellectual property and what does its platform actually do?
The firm's public disclosures state it offers a white-label platform that provides patient engagement and digital marketing services to healthcare practices. The company markets itself primarily through its corporate website and public filings, but it has not announced any notable enterprise partnerships, case studies, or observable revenue from scaled platform deployments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: